N Lynn Henry


Ontology type: schema:Person     


Person Info

NAME

N Lynn

SURNAME

Henry

Publications in SciGraph latest 50 shown

  • 2018-10 Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-12 Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer in THE PHARMACOGENOMICS JOURNAL
  • 2017-10 Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-07 Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-06 Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-03 Extended Endocrine Therapy: Is 5 Years Enough? in CURRENT ONCOLOGY REPORTS
  • 2017-02 Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-06 Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-02 Clinical predictors of long-term survival in HER2-positive metastatic breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-01 Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-11 Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-11 Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-07 Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-10 Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects in BRITISH JOURNAL OF CANCER
  • 2013-04 Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-06 Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-02 Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2011-11 Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2011-02 One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy in BREAST CANCER RESEARCH AND TREATMENT
  • 2010-11 Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated Results in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2010-07 Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study in BRITISH JOURNAL OF CANCER
  • 2010-01 Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy in BRITISH JOURNAL OF CANCER
  • 2009-10 Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort in BREAST CANCER RESEARCH AND TREATMENT
  • 2009-08 Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients in THE PHARMACOGENOMICS JOURNAL
  • 2008-09 Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors in BREAST CANCER RESEARCH AND TREATMENT
  • 2008 Clinical Importance of Prognostic Factors in PRINCIPLES OF MOLECULAR ONCOLOGY
  • 2006-11 Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants in NATURE REVIEWS CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.223827.e", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412590.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.214458.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.479969.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.47100.32", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.427738.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.270240.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412722.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "Henry", 
        "givenName": "N  Lynn", 
        "id": "sg:person.01042733643.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042733643.27"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:49", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_559.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01042733643.27'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01042733643.27'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01042733643.27'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01042733643.27'


     

    This table displays all metadata directly associated to this object as RDF triples.

    32 TRIPLES      10 PREDICATES      19 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01042733643.27 schema:affiliation Na7cdc62dbe694205aa328453b355735b
    2 https://www.grid.ac/institutes/grid.214458.e
    3 https://www.grid.ac/institutes/grid.270240.3
    4 https://www.grid.ac/institutes/grid.412590.b
    5 https://www.grid.ac/institutes/grid.412722.0
    6 https://www.grid.ac/institutes/grid.427738.d
    7 https://www.grid.ac/institutes/grid.47100.32
    8 https://www.grid.ac/institutes/grid.479969.c
    9 https://www.grid.ac/institutes/grid.65499.37
    10 schema:familyName Henry
    11 schema:givenName N Lynn
    12 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042733643.27
    13 schema:sdDatePublished 2019-03-07T14:49
    14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    15 schema:sdPublisher Nec74b142e8e44607864740c3ab36a995
    16 sgo:license sg:explorer/license/
    17 sgo:sdDataset persons
    18 rdf:type schema:Person
    19 Na7cdc62dbe694205aa328453b355735b schema:affiliation https://www.grid.ac/institutes/grid.223827.e
    20 sgo:isCurrent true
    21 rdf:type schema:OrganizationRole
    22 Nec74b142e8e44607864740c3ab36a995 schema:name Springer Nature - SN SciGraph project
    23 rdf:type schema:Organization
    24 https://www.grid.ac/institutes/grid.214458.e schema:Organization
    25 https://www.grid.ac/institutes/grid.223827.e schema:Organization
    26 https://www.grid.ac/institutes/grid.270240.3 schema:Organization
    27 https://www.grid.ac/institutes/grid.412590.b schema:Organization
    28 https://www.grid.ac/institutes/grid.412722.0 schema:Organization
    29 https://www.grid.ac/institutes/grid.427738.d schema:Organization
    30 https://www.grid.ac/institutes/grid.47100.32 schema:Organization
    31 https://www.grid.ac/institutes/grid.479969.c schema:Organization
    32 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...